Cramer’s lightning round: Wolfspeed is not a buy

Cramer’s lightning round: Wolfspeed is not a buy


Enovix Corp: “I have to say [sell] because It costs too much money.”

Wolfspeed Inc: “I’m going to tell you not to buy. This stock doesn’t make money.”

Stem Inc: “A company that does not make a lot of money with a high stock in an era when the Fed wants to crunch inflation is not a stock you can own.”

Jim Cramer’s Guide to Investing

Click here to download Jim Cramer’s Guide to Investing at no cost to help you build long-term wealth and invest smarter.



Source

Novo Nordisk’s explosive Wegovy pill launch draws a new wave of patients into GLP-1 weight loss treatment
Business

Novo Nordisk’s explosive Wegovy pill launch draws a new wave of patients into GLP-1 weight loss treatment

After years of trying to lose weight “the right way,” Jane Zuckerman realized that “putting in the work just wasn’t enough.”  Zuckerman, a 32-year-old data analyst based in Washington, D.C., said she lost 90 pounds in college and spent years cycling through nutritionists, therapy and strict routines — only to find herself at her heaviest […]

Read More
Iran war upends spring housing market. Here’s what real estate agents are seeing
Business

Iran war upends spring housing market. Here’s what real estate agents are seeing

FILE PHOTO: A for sale sign is shown for a residential home in Encinitas, California, U.S. July 25, 2025. Mike Blake | Reuters A version of this article first appeared in the CNBC Property Play newsletter with Diana Olick. Property Play covers new and evolving opportunities for the real estate investor, from individuals to venture […]

Read More
Trump administration finalizes better-than-feared Medicare Advantage payment rate in boost to health insurers
Business

Trump administration finalizes better-than-feared Medicare Advantage payment rate in boost to health insurers

Administrator for the Centers for Medicare & Medicaid Services Mehmet Oz speaks during an event sponsored by the Action for Progress Coalition, at the National Press Club in Washington, D.C., U.S., Feb. 2, 2026. Al Drago | Reuters The Trump administration on Monday finalized a 2027 payment rate increase to privately run Medicare plans that […]

Read More